Last 12 months
Inside the activity.
0 purchase rows · 26 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 4 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 2 |
| Mar 2026 | 0 | 2 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 3 |
| Jun 2026 | 0 | 7 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 3 |
| Sep 2026 | 0 | 5 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| June 01, 2022 Filed Jun 2, 2022 23:22 UTC |
HAMERSLAG STEVEN JDirector
|
SaleCommon Stock | 1,000 | $147.98 | $147,979.20 |
DisclosureSEC source: 0001056168-22-000002 · edgardoc.xml · nonDerivative · entry 4 HAMERSLAG STEVEN J · CIK 0001056168 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 120,468 Read SEC document |
| June 01, 2022 Filed Jun 2, 2022 23:22 UTC |
HAMERSLAG STEVEN JDirector
|
Exercise / conversionCommon Stock | 1,000 | $40.57 | $40,570.00 |
DisclosureSEC source: 0001056168-22-000002 · edgardoc.xml · nonDerivative · entry 3 HAMERSLAG STEVEN J · CIK 0001056168 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 121,468 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 31, 2022 Filed Jun 2, 2022 23:22 UTC |
HAMERSLAG STEVEN JDirector
|
Exercise / conversionNon-Qualified Stock Option (right to buy) · Derivative | 2,000 | $0.00 Strike: $40.57 | $0.00 |
DisclosureSEC source: 0001056168-22-000002 · edgardoc.xml · derivative · entry 11 HAMERSLAG STEVEN J · CIK 0001056168 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,000 Underlying: Common Stock · 2,000 shares Expires 2024-08-04 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: Exercisable in a series of 4 equal and successive annual installments commencing 12 months following the date of grant. Read SEC document |
| May 31, 2022 Filed Jun 2, 2022 23:22 UTC |
HAMERSLAG STEVEN JDirector
|
SaleCommon Stock | 2,000 | $149.34 | $298,685.80 |
DisclosureSEC source: 0001056168-22-000002 · edgardoc.xml · nonDerivative · entry 2 HAMERSLAG STEVEN J · CIK 0001056168 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 120,468 Read SEC document |
| May 31, 2022 Filed Jun 2, 2022 23:22 UTC |
HAMERSLAG STEVEN JDirector
|
Exercise / conversionCommon Stock | 2,000 | $40.57 | $81,140.00 |
DisclosureSEC source: 0001056168-22-000002 · edgardoc.xml · nonDerivative · entry 1 HAMERSLAG STEVEN J · CIK 0001056168 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 122,468 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 12, 2022 Filed May 14, 2022 01:57 UTC |
Yoss JenniferVice President of Accounting
|
GrantNon-Qualified Stock Option (right to buy) · Derivative | 300 | $0.00 Strike: $148.89 | $0.00 |
DisclosureSEC source: 0001754632-22-000007 · edgardoc.xml · derivative · entry 1 Yoss Jennifer · CIK 0001754632 · Vice President of Accounting 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 300 Underlying: Common Stock · 300 shares Expires 2027-05-12 F1 · derivative.exercise_date: Exercisable as to 25% of shares one year following grant date with the remaining shares exercisable in 36 equal monthly installments thereafter. Read SEC document |
| May 12, 2022 Filed May 14, 2022 01:49 UTC |
Shishin MaximChief Information Officer
|
GrantNon-Qualified Stock Option (right to buy) · Derivative | 500 | $0.00 Strike: $148.89 | $0.00 |
DisclosureSEC source: 0001703039-22-000004 · edgardoc.xml · derivative · entry 1 Shishin Maxim · CIK 0001703039 · Chief Information Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 500 Underlying: Common Stock · 500 shares Expires 2027-05-12 F1 · derivative.exercise_date: Exercisable as to 25% of shares one year following grant date with the remaining shares exercisable in 36 equal monthly installments thereafter. Read SEC document |
| May 12, 2022 Filed May 14, 2022 01:41 UTC |
O'Brien BrandonChief Financial Officer
|
GrantNon-Qualified Stock Option (right to buy) · Derivative | 500 | $0.00 Strike: $148.89 | $0.00 |
DisclosureSEC source: 0001754499-22-000004 · edgardoc.xml · derivative · entry 1 O'Brien Brandon · CIK 0001754499 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 500 Underlying: Common Stock · 500 shares Expires 2027-05-12 F1 · derivative.exercise_date: Exercisable as to 25% of shares one year following grant date with the remaining shares exercisable in 36 equal monthly installments thereafter. Read SEC document |
| May 12, 2022 Filed May 14, 2022 01:33 UTC |
Combs Michael GCEO & President
|
GrantNon-Qualified Stock Option (right to buy) · Derivative | 7,500 | $0.00 Strike: $148.89 | $0.00 |
DisclosureSEC source: 0001641248-22-000008 · edgardoc.xml · derivative · entry 1 Combs Michael G · CIK 0001641248 · CEO & President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,500 Underlying: Common Stock · 7,500 shares Expires 2027-05-12 F1 · derivative.exercise_date: Exercisable as to 25% of shares one year following grant date with the remaining shares exercisable in 36 equal monthly installments thereafter. Read SEC document |
| May 12, 2022 Filed May 14, 2022 01:21 UTC |
Bertels Mark E.EVP - Risk Management Services
|
GrantNon-Qualified Stock Option (right to buy) · Derivative | 5,250 | $0.00 Strike: $148.89 | $0.00 |
DisclosureSEC source: 0001921051-22-000004 · edgardoc.xml · derivative · entry 1 Bertels Mark E. · CIK 0001921051 · EVP - Risk Management Services 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,250 Underlying: Common Stock · 5,250 shares Expires 2027-05-12 F1 · derivative.exercise_date: Exercisable as to 25% of shares one year following grant date with the remaining shares exercisable in 36 equal monthly installments thereafter. Read SEC document |
| April 22, 2022 Filed Apr 25, 2022 22:36 UTC |
CLEMONS V GORDONDirector · Chairman of the Board
|
SaleCommon Stock | 667 | $172.01 | $114,733.27 |
DisclosureSEC source: 0000946724-22-000022 · edgardoc.xml · nonDerivative · entry 2 CLEMONS V GORDON · CIK 0000946724 · Director · Chairman of the Board 10b5-1 filing: Not disclosed Ownership: Indirect · Spouse Living Trust Disclosed balance after: 455,920 F1 · kind: Sales reported above were made pursuant to a Rule 10b5-1 trading plan adopted on March 2, 2022. F2 · balance_after: The reported transaction was made by the Marie Eve Clemons Living Trust. The reporting person disclaims beneficial ownership to these securities, and this report shall not be deemed an admission that the reporting person is the beneficial owner of such securities for Section 16 purposes. Read SEC document |
| April 21, 2022 Filed Apr 25, 2022 22:36 UTC |
CLEMONS V GORDONDirector · Chairman of the Board
|
SaleCommon Stock | 1,000 | $181.77 | $181,767.90 |
DisclosureSEC source: 0000946724-22-000022 · edgardoc.xml · nonDerivative · entry 1 CLEMONS V GORDON · CIK 0000946724 · Director · Chairman of the Board 10b5-1 filing: Not disclosed Ownership: Indirect · Spouse Living Trust Disclosed balance after: 456,587 F1 · kind: Sales reported above were made pursuant to a Rule 10b5-1 trading plan adopted on March 2, 2022. F2 · balance_after: The reported transaction was made by the Marie Eve Clemons Living Trust. The reporting person disclaims beneficial ownership to these securities, and this report shall not be deemed an admission that the reporting person is the beneficial owner of such securities for Section 16 purposes. Read SEC document |
| April 20, 2022 Filed Apr 20, 2022 21:45 UTC |
CLEMONS V GORDONDirector · Chairman of the Board
|
SaleCommon Stock | 1,429 | $179.65 | $256,717.13 |
DisclosureSEC source: 0000946724-22-000020 · edgardoc.xml · nonDerivative · entry 3 CLEMONS V GORDON · CIK 0000946724 · Director · Chairman of the Board 10b5-1 filing: Not disclosed Ownership: Indirect · Spouse Living Trust Disclosed balance after: 457,587 F1 · kind: Sales reported above were made pursuant to a Rule 10b5-1 trading plan adopted on March 2, 2022. F2 · balance_after: The reported transaction was made by the Marie Eve Clemons Living Trust. The reporting person disclaims beneficial ownership to these securities, and this report shall not be deemed an admission that the reporting person is the beneficial owner of such securities for Section 16 purposes. Read SEC document |
| April 19, 2022 Filed Apr 20, 2022 21:45 UTC |
CLEMONS V GORDONDirector · Chairman of the Board
|
SaleCommon Stock | 1,237 | $177.41 | $219,460.99 |
DisclosureSEC source: 0000946724-22-000020 · edgardoc.xml · nonDerivative · entry 2 CLEMONS V GORDON · CIK 0000946724 · Director · Chairman of the Board 10b5-1 filing: Not disclosed Ownership: Indirect · Spouse Living Trust Disclosed balance after: 459,016 F1 · kind: Sales reported above were made pursuant to a Rule 10b5-1 trading plan adopted on March 2, 2022. F2 · balance_after: The reported transaction was made by the Marie Eve Clemons Living Trust. The reporting person disclaims beneficial ownership to these securities, and this report shall not be deemed an admission that the reporting person is the beneficial owner of such securities for Section 16 purposes. Read SEC document |
| April 18, 2022 Filed Apr 20, 2022 21:45 UTC |
CLEMONS V GORDONDirector · Chairman of the Board
|
SaleCommon Stock | 1,334 | $176.51 | $235,459.80 |
DisclosureSEC source: 0000946724-22-000020 · edgardoc.xml · nonDerivative · entry 1 CLEMONS V GORDON · CIK 0000946724 · Director · Chairman of the Board 10b5-1 filing: Not disclosed Ownership: Indirect · Spouse Living Trust Disclosed balance after: 460,253 F1 · kind: Sales reported above were made pursuant to a Rule 10b5-1 trading plan adopted on March 2, 2022. F2 · balance_after: The reported transaction was made by the Marie Eve Clemons Living Trust. The reporting person disclaims beneficial ownership to these securities, and this report shall not be deemed an admission that the reporting person is the beneficial owner of such securities for Section 16 purposes. Read SEC document |
| April 14, 2022 Filed Apr 14, 2022 21:44 UTC |
CLEMONS V GORDONDirector · Chairman of the Board
|
SaleCommon Stock | 2,264 | $179.67 | $406,767.22 |
DisclosureSEC source: 0000946724-22-000018 · edgardoc.xml · nonDerivative · entry 3 CLEMONS V GORDON · CIK 0000946724 · Director · Chairman of the Board 10b5-1 filing: Not disclosed Ownership: Indirect · Spouse Living Trust Disclosed balance after: 461,587 F1 · kind: Sales reported above were made pursuant to a Rule 10b5-1 trading plan adopted on March 2, 2022. F2 · balance_after: The reported transaction was made by the Marie Eve Clemons Living Trust. The reporting person disclaims beneficial ownership to these securities, and this report shall not be deemed an admission that the reporting person is the beneficial owner of such securities for Section 16 purposes. Read SEC document |
| April 14, 2022 Filed Apr 15, 2022 21:53 UTC |
BLAHA DIANEChief Marketing Officer
|
Exercise / conversionNon-Qualified Stock Option (right to buy) · Derivative | 125 | $178.82 Strike: $45.90 | $22,352.50 |
DisclosureSEC source: 0001450607-22-000005 · edgardoc.xml · derivative · entry 4 BLAHA DIANE · CIK 0001450607 · Chief Marketing Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 125 shares Expires 2022-05-04 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: Exercisable as to 25% of shares one year following grant date with the remaining shares exercisable in 36 equal monthly installments thereafter. Read SEC document |
| April 14, 2022 Filed Apr 15, 2022 21:53 UTC |
BLAHA DIANEChief Marketing Officer
|
Tax withholdingCommon Stock | 27 | $178.82 | $4,828.14 |
DisclosureSEC source: 0001450607-22-000005 · edgardoc.xml · nonDerivative · entry 3 BLAHA DIANE · CIK 0001450607 · Chief Marketing Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,423 F1 · kind: Shares delivered in payment of the option exercise price and/or tax liability incident to the option exercise. Read SEC document |
| April 14, 2022 Filed Apr 15, 2022 21:53 UTC |
BLAHA DIANEChief Marketing Officer
|
Tax withholdingCommon Stock | 32 | $178.82 | $5,722.24 |
DisclosureSEC source: 0001450607-22-000005 · edgardoc.xml · nonDerivative · entry 2 BLAHA DIANE · CIK 0001450607 · Chief Marketing Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,450 F1 · kind: Shares delivered in payment of the option exercise price and/or tax liability incident to the option exercise. Read SEC document |
| April 14, 2022 Filed Apr 15, 2022 21:53 UTC |
BLAHA DIANEChief Marketing Officer
|
Exercise / conversionCommon Stock | 125 | $45.90 | $5,737.50 |
DisclosureSEC source: 0001450607-22-000005 · edgardoc.xml · nonDerivative · entry 1 BLAHA DIANE · CIK 0001450607 · Chief Marketing Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,482 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| April 13, 2022 Filed Apr 14, 2022 21:44 UTC |
CLEMONS V GORDONDirector · Chairman of the Board
|
SaleCommon Stock | 2,067 | $179.30 | $370,610.62 |
DisclosureSEC source: 0000946724-22-000018 · edgardoc.xml · nonDerivative · entry 2 CLEMONS V GORDON · CIK 0000946724 · Director · Chairman of the Board 10b5-1 filing: Not disclosed Ownership: Indirect · Spouse Living Trust Disclosed balance after: 463,851 F1 · kind: Sales reported above were made pursuant to a Rule 10b5-1 trading plan adopted on March 2, 2022. F2 · balance_after: The reported transaction was made by the Marie Eve Clemons Living Trust. The reporting person disclaims beneficial ownership to these securities, and this report shall not be deemed an admission that the reporting person is the beneficial owner of such securities for Section 16 purposes. Read SEC document |
| April 12, 2022 Filed Apr 14, 2022 21:44 UTC |
CLEMONS V GORDONDirector · Chairman of the Board
|
SaleCommon Stock | 667 | $175.54 | $117,084.25 |
DisclosureSEC source: 0000946724-22-000018 · edgardoc.xml · nonDerivative · entry 1 CLEMONS V GORDON · CIK 0000946724 · Director · Chairman of the Board 10b5-1 filing: Not disclosed Ownership: Indirect · Spouse Living Trust Disclosed balance after: 465,918 F1 · kind: Sales reported above were made pursuant to a Rule 10b5-1 trading plan adopted on March 2, 2022. F2 · balance_after: The reported transaction was made by the Marie Eve Clemons Living Trust. The reporting person disclaims beneficial ownership to these securities, and this report shall not be deemed an admission that the reporting person is the beneficial owner of such securities for Section 16 purposes. Read SEC document |
| April 11, 2022 Filed Apr 11, 2022 21:39 UTC |
CLEMONS V GORDONDirector · Chairman of the Board
|
SaleCommon Stock | 667 | $173.70 | $115,856.83 |
DisclosureSEC source: 0000946724-22-000016 · edgardoc.xml · nonDerivative · entry 3 CLEMONS V GORDON · CIK 0000946724 · Director · Chairman of the Board 10b5-1 filing: Not disclosed Ownership: Indirect · Spouse Living Trust Disclosed balance after: 466,585 F1 · kind: Sales reported above were made pursuant to a Rule 10b5-1 trading plan adopted on March 2, 2022. F2 · balance_after: The reported transaction was made by the Marie Eve Clemons Living Trust. The reporting person disclaims beneficial ownership to these securities, and this report shall not be deemed an admission that the reporting person is the beneficial owner of such securities for Section 16 purposes. Read SEC document |
| April 08, 2022 Filed Apr 11, 2022 21:39 UTC |
CLEMONS V GORDONDirector · Chairman of the Board
|
SaleCommon Stock | 667 | $173.99 | $116,048.73 |
DisclosureSEC source: 0000946724-22-000016 · edgardoc.xml · nonDerivative · entry 2 CLEMONS V GORDON · CIK 0000946724 · Director · Chairman of the Board 10b5-1 filing: Not disclosed Ownership: Indirect · Spouse Living Trust Disclosed balance after: 467,252 F1 · kind: Sales reported above were made pursuant to a Rule 10b5-1 trading plan adopted on March 2, 2022. F2 · balance_after: The reported transaction was made by the Marie Eve Clemons Living Trust. The reporting person disclaims beneficial ownership to these securities, and this report shall not be deemed an admission that the reporting person is the beneficial owner of such securities for Section 16 purposes. Read SEC document |
| April 07, 2022 Filed Apr 11, 2022 21:39 UTC |
CLEMONS V GORDONDirector · Chairman of the Board
|
SaleCommon Stock | 667 | $169.82 | $113,267.94 |
DisclosureSEC source: 0000946724-22-000016 · edgardoc.xml · nonDerivative · entry 1 CLEMONS V GORDON · CIK 0000946724 · Director · Chairman of the Board 10b5-1 filing: Not disclosed Ownership: Indirect · Spouse Living Trust Disclosed balance after: 467,919 F1 · kind: Sales reported above were made pursuant to a Rule 10b5-1 trading plan adopted on March 2, 2022. F2 · balance_after: The reported transaction was made by the Marie Eve Clemons Living Trust. The reporting person disclaims beneficial ownership to these securities, and this report shall not be deemed an admission that the reporting person is the beneficial owner of such securities for Section 16 purposes. Read SEC document |
| April 06, 2022 Filed Apr 6, 2022 21:32 UTC |
CLEMONS V GORDONDirector · Chairman of the Board
|
SaleCommon Stock | 667 | $169.06 | $112,763.55 |
DisclosureSEC source: 0000946724-22-000014 · edgardoc.xml · nonDerivative · entry 3 CLEMONS V GORDON · CIK 0000946724 · Director · Chairman of the Board 10b5-1 filing: Not disclosed Ownership: Indirect · Spouse Living Trust Disclosed balance after: 468,586 F1 · kind: Sales reported above were made pursuant to a Rule 10b5-1 trading plan adopted on March 2, 2022. F2 · balance_after: The reported transaction was made by the Marie Eve Clemons Living Trust. The reporting person disclaims beneficial ownership to these securities, and this report shall not be deemed an admission that the reporting person is the beneficial owner of such securities for Section 16 purposes. Read SEC document |
| April 05, 2022 Filed Apr 6, 2022 21:55 UTC |
Yoss JenniferVice President of Accounting
|
Exercise / conversionNon-Qualified Stock Option (right to buy) · Derivative | 62 | $170.02 Strike: $48.35 | $10,541.24 |
DisclosureSEC source: 0001754632-22-000005 · edgardoc.xml · derivative · entry 4 Yoss Jennifer · CIK 0001754632 · Vice President of Accounting 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 62 shares Expires 2022-08-03 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: Exercisable as to 25% of shares one year following grant date with the remaining shares exercisable in 36 equal monthly installments thereafter. Read SEC document |
| April 05, 2022 Filed Apr 6, 2022 21:55 UTC |
Yoss JenniferVice President of Accounting
|
Tax withholdingCommon Stock | 17 | $170.02 | $2,890.34 |
DisclosureSEC source: 0001754632-22-000005 · edgardoc.xml · nonDerivative · entry 3 Yoss Jennifer · CIK 0001754632 · Vice President of Accounting 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 289 F1 · kind: Shares delivered in payment of the option exercise price and/or tax liability incident to the option exercise. Read SEC document |
| April 05, 2022 Filed Apr 6, 2022 21:55 UTC |
Yoss JenniferVice President of Accounting
|
Tax withholdingCommon Stock | 17 | $170.02 | $2,890.34 |
DisclosureSEC source: 0001754632-22-000005 · edgardoc.xml · nonDerivative · entry 2 Yoss Jennifer · CIK 0001754632 · Vice President of Accounting 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 306 F1 · kind: Shares delivered in payment of the option exercise price and/or tax liability incident to the option exercise. Read SEC document |
| April 05, 2022 Filed Apr 6, 2022 21:55 UTC |
Yoss JenniferVice President of Accounting
|
Exercise / conversionCommon Stock | 62 | $48.35 | $2,997.70 |
DisclosureSEC source: 0001754632-22-000005 · edgardoc.xml · nonDerivative · entry 1 Yoss Jennifer · CIK 0001754632 · Vice President of Accounting 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 323 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| April 05, 2022 Filed Apr 6, 2022 21:32 UTC |
CLEMONS V GORDONDirector · Chairman of the Board
|
SaleCommon Stock | 667 | $168.99 | $112,716.33 |
DisclosureSEC source: 0000946724-22-000014 · edgardoc.xml · nonDerivative · entry 2 CLEMONS V GORDON · CIK 0000946724 · Director · Chairman of the Board 10b5-1 filing: Not disclosed Ownership: Indirect · Spouse Living Trust Disclosed balance after: 469,253 F1 · kind: Sales reported above were made pursuant to a Rule 10b5-1 trading plan adopted on March 2, 2022. F2 · balance_after: The reported transaction was made by the Marie Eve Clemons Living Trust. The reporting person disclaims beneficial ownership to these securities, and this report shall not be deemed an admission that the reporting person is the beneficial owner of such securities for Section 16 purposes. Read SEC document |
| April 04, 2022 Filed Apr 6, 2022 21:32 UTC |
CLEMONS V GORDONDirector · Chairman of the Board
|
SaleCommon Stock | 667 | $171.62 | $114,471.07 |
DisclosureSEC source: 0000946724-22-000014 · edgardoc.xml · nonDerivative · entry 1 CLEMONS V GORDON · CIK 0000946724 · Director · Chairman of the Board 10b5-1 filing: Not disclosed Ownership: Indirect · Spouse Living Trust Disclosed balance after: 469,920 F1 · kind: Sales reported above were made pursuant to a Rule 10b5-1 trading plan adopted on March 2, 2022. F2 · balance_after: The reported transaction was made by the Marie Eve Clemons Living Trust. The reporting person disclaims beneficial ownership to these securities, and this report shall not be deemed an admission that the reporting person is the beneficial owner of such securities for Section 16 purposes. Read SEC document |
| March 31, 2022 Filed Apr 1, 2022 22:26 UTC |
Yoss JenniferVice President of Accounting
|
GrantCommon Stock | 16 | $160.02 | $2,560.29 |
DisclosureSEC source: 0001754632-22-000003 · edgardoc.xml · nonDerivative · entry 1 Yoss Jennifer · CIK 0001754632 · Vice President of Accounting 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 261 F1 · balance_after: Shares acquired under the Issuer's Employee Stock Purchase Plan in a transaction exempt under SEC Rule 16b-3 (c) Read SEC document |
| March 31, 2022 Filed Apr 1, 2022 22:05 UTC |
O'Brien BrandonChief Financial Officer
|
GrantCommon Stock | 8 | $160.02 | $1,280.14 |
DisclosureSEC source: 0001754499-22-000002 · edgardoc.xml · nonDerivative · entry 1 O'Brien Brandon · CIK 0001754499 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,664 F1 · balance_after: Shares acquired under the Issuer's Employee Stock Purchase Plan in a transaction exempt under SEC Rule 16b-3 (c) Read SEC document |
| March 31, 2022 Filed Apr 1, 2022 21:48 UTC |
Combs Michael GCEO & President
|
GrantCommon Stock | 20 | $160.02 | $3,200.36 |
DisclosureSEC source: 0001641248-22-000006 · edgardoc.xml · nonDerivative · entry 1 Combs Michael G · CIK 0001641248 · CEO & President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,025 F1 · balance_after: Shares acquired under the Issuer's Employee Stock Purchase Plan in a transaction exempt under SEC Rule 16b-3 (c) Read SEC document |
| March 31, 2022 Filed Apr 1, 2022 21:27 UTC |
BLAHA DIANEChief Marketing Officer
|
GrantCommon Stock | 73 | $160.02 | $11,681.31 |
DisclosureSEC source: 0001450607-22-000003 · edgardoc.xml · nonDerivative · entry 1 BLAHA DIANE · CIK 0001450607 · Chief Marketing Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,357 F1 · balance_after: Shares acquired under the Issuer's Employee Stock Purchase Plan in a transaction exempt under SEC Rule 16b-3 (c) Read SEC document |
| March 18, 2022 Filed Mar 18, 2022 21:47 UTC |
CLEMONS V GORDONDirector · Chairman of the Board
|
SaleCommon Stock | 1,000 | $172.00 | $172,000.00 |
DisclosureSEC source: 0000946724-22-000012 · edgardoc.xml · nonDerivative · entry 3 CLEMONS V GORDON · CIK 0000946724 · Director · Chairman of the Board 10b5-1 filing: Not disclosed Ownership: Indirect · Spouse Living Trust Disclosed balance after: 469,587 F1 · balance_after: The reported transaction was made by the Marie Eve Clemons Living Trust. The reporting person disclaims beneficial ownership to these securities, and this report shall not be deemed an admission that the reporting person is the beneficial owner of such securities for Section 16 purposes. Read SEC document |
| March 17, 2022 Filed Mar 18, 2022 21:47 UTC |
CLEMONS V GORDONDirector · Chairman of the Board
|
SaleCommon Stock | 1,000 | $170.00 | $170,000.00 |
DisclosureSEC source: 0000946724-22-000012 · edgardoc.xml · nonDerivative · entry 2 CLEMONS V GORDON · CIK 0000946724 · Director · Chairman of the Board 10b5-1 filing: Not disclosed Ownership: Indirect · Spouse Living Trust Disclosed balance after: 470,587 F1 · balance_after: The reported transaction was made by the Marie Eve Clemons Living Trust. The reporting person disclaims beneficial ownership to these securities, and this report shall not be deemed an admission that the reporting person is the beneficial owner of such securities for Section 16 purposes. Read SEC document |
| March 16, 2022 Filed Mar 18, 2022 21:47 UTC |
CLEMONS V GORDONDirector · Chairman of the Board
|
SaleCommon Stock | 2,000 | $163.50 | $327,000.00 |
DisclosureSEC source: 0000946724-22-000012 · edgardoc.xml · nonDerivative · entry 1 CLEMONS V GORDON · CIK 0000946724 · Director · Chairman of the Board 10b5-1 filing: Not disclosed Ownership: Indirect · Spouse Living Trust Disclosed balance after: 471,587 F1 · balance_after: The reported transaction was made by the Marie Eve Clemons Living Trust. The reporting person disclaims beneficial ownership to these securities, and this report shall not be deemed an admission that the reporting person is the beneficial owner of such securities for Section 16 purposes. Read SEC document |
| March 07, 2022 Filed Mar 9, 2022 22:38 UTC |
Shishin MaximChief Information Officer
|
Exercise / conversionNon-Qualified Stock Option (right to buy) · Derivative | 500 | $0.00 Strike: $45.90 | $0.00 |
DisclosureSEC source: 0001703039-22-000002 · edgardoc.xml · derivative · entry 3 Shishin Maxim · CIK 0001703039 · Chief Information Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 500 shares Expires 2022-05-04 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: Exercisable as to 25% of shares one year following grant date with the remaining shares exercisable in 36 equal monthly installments thereafter. Read SEC document |
| March 07, 2022 Filed Mar 9, 2022 22:38 UTC |
Shishin MaximChief Information Officer
|
SaleCommon Stock | 500 | $164.62 | $82,309.65 |
DisclosureSEC source: 0001703039-22-000002 · edgardoc.xml · nonDerivative · entry 2 Shishin Maxim · CIK 0001703039 · Chief Information Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 600 Read SEC document |
| March 07, 2022 Filed Mar 9, 2022 22:38 UTC |
Shishin MaximChief Information Officer
|
Exercise / conversionCommon Stock | 500 | $45.90 | $22,950.00 |
DisclosureSEC source: 0001703039-22-000002 · edgardoc.xml · nonDerivative · entry 1 Shishin Maxim · CIK 0001703039 · Chief Information Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,100 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 02, 2022 Filed Mar 2, 2022 23:09 UTC |
CLEMONS V GORDONDirector · Chairman of the Board
|
SaleCommon Stock | 1,000 | $168.02 | $168,020.30 |
DisclosureSEC source: 0000946724-22-000010 · edgardoc.xml · nonDerivative · entry 3 CLEMONS V GORDON · CIK 0000946724 · Director · Chairman of the Board 10b5-1 filing: Not disclosed Ownership: Indirect · Spouse Living Trust Disclosed balance after: 473,587 F2 · balance_after: The reported transaction was made by the Marie Eve Clemons Living Trust. The reporting person disclaims beneficial ownership to these securities, and this report shall not be deemed an admission that the reporting person is the beneficial owner of such securities for Section 16 purposes. Read SEC document |
| March 01, 2022 Filed Mar 2, 2022 23:09 UTC |
CLEMONS V GORDONDirector · Chairman of the Board
|
SaleCommon Stock | 2,000 | $162.50 | $325,000.00 |
DisclosureSEC source: 0000946724-22-000010 · edgardoc.xml · nonDerivative · entry 2 CLEMONS V GORDON · CIK 0000946724 · Director · Chairman of the Board 10b5-1 filing: Not disclosed Ownership: Indirect · Spouse Living Trust Disclosed balance after: 474,587 F2 · balance_after: The reported transaction was made by the Marie Eve Clemons Living Trust. The reporting person disclaims beneficial ownership to these securities, and this report shall not be deemed an admission that the reporting person is the beneficial owner of such securities for Section 16 purposes. Read SEC document |
| February 28, 2022 Filed Mar 2, 2022 23:09 UTC |
CLEMONS V GORDONDirector · Chairman of the Board
|
GiftCommon Stock | 2,250 | $0.00 | $0.00 |
DisclosureSEC source: 0000946724-22-000010 · edgardoc.xml · nonDerivative · entry 1 CLEMONS V GORDON · CIK 0000946724 · Director · Chairman of the Board 10b5-1 filing: Not disclosed Ownership: Indirect · Spouse Living Trust Disclosed balance after: 476,587 F1 · balance_after: The reported gift was made by the Marie Eve Clemons Living Trust to the Marie Clemons Exempt Trust. The reporting person disclaims beneficial ownership of these securities, and this report shall not be deemed an admission that the reporting person is the beneficial owner of such securities for Section 16 purposes. Read SEC document |
| February 23, 2022 Filed Feb 24, 2022 23:25 UTC |
CLEMONS V GORDONDirector · Chairman of the Board
|
SaleCommon Stock | 1,000 | $163.00 | $163,000.00 |
DisclosureSEC source: 0000946724-22-000008 · edgardoc.xml · nonDerivative · entry 2 CLEMONS V GORDON · CIK 0000946724 · Director · Chairman of the Board 10b5-1 filing: Not disclosed Ownership: Indirect · Spouse Living Trust Disclosed balance after: 478,837 F1 · balance_after: The reported transaction was made by the Marie Eve Clemons Living Trust. The reporting person disclaims beneficial ownership to these securities, and this report shall not be deemed an admission that the reporting person is the beneficial owner of such securities for Section 16 purposes. Read SEC document |
| February 23, 2022 Filed Feb 24, 2022 22:41 UTC |
Combs Michael GCEO & President
|
SaleCommon Stock | 4,229 | $162.50 | $687,212.50 |
DisclosureSEC source: 0001641248-22-000004 · edgardoc.xml · nonDerivative · entry 2 Combs Michael G · CIK 0001641248 · CEO & President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,005 Read SEC document |
| February 22, 2022 Filed Feb 24, 2022 23:25 UTC |
CLEMONS V GORDONDirector · Chairman of the Board
|
SaleCommon Stock | 1,000 | $161.00 | $161,000.00 |
DisclosureSEC source: 0000946724-22-000008 · edgardoc.xml · nonDerivative · entry 1 CLEMONS V GORDON · CIK 0000946724 · Director · Chairman of the Board 10b5-1 filing: Not disclosed Ownership: Indirect · Spouse Living Trust Disclosed balance after: 479,837 F1 · balance_after: The reported transaction was made by the Marie Eve Clemons Living Trust. The reporting person disclaims beneficial ownership to these securities, and this report shall not be deemed an admission that the reporting person is the beneficial owner of such securities for Section 16 purposes. Read SEC document |
| February 22, 2022 Filed Feb 24, 2022 22:41 UTC |
Combs Michael GCEO & President
|
SaleCommon Stock | 200 | $162.61 | $32,522.80 |
DisclosureSEC source: 0001641248-22-000004 · edgardoc.xml · nonDerivative · entry 1 Combs Michael G · CIK 0001641248 · CEO & President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,234 Read SEC document |
| February 17, 2022 Filed Feb 17, 2022 23:37 UTC |
CLEMONS V GORDONDirector · Chairman of the Board
|
SaleCommon Stock | 1,000 | $165.00 | $165,000.00 |
DisclosureSEC source: 0000946724-22-000006 · edgardoc.xml · nonDerivative · entry 3 CLEMONS V GORDON · CIK 0000946724 · Director · Chairman of the Board 10b5-1 filing: Not disclosed Ownership: Indirect · Spouse Living Trust Disclosed balance after: 480,837 F1 · balance_after: The reported transaction was made by the Marie Eve Clemons Living Trust. The reporting person disclaims beneficial ownership to these securities, and this report shall not be deemed an admission that the reporting person is the beneficial owner of such securities for Section 16 purposes. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.